255 related articles for article (PubMed ID: 12212196)
1. [Chemically induced (streptozotocin-alloxan) diabetes mellitus in dogs].
Liu S; Wang W; Luo XM; Ye B
Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):125-8. PubMed ID: 12212196
[TBL] [Abstract][Full Text] [Related]
2. Chemically induced (streptozotocin-alloxan) diabetes mellitus in the dog. Biochemical and ultrastructural studies.
Black HE; Rosenblum IY; Capen CC
Am J Pathol; 1980 Feb; 98(2):295-310. PubMed ID: 6444498
[TBL] [Abstract][Full Text] [Related]
3. [Experimental models in research of the pathomechanism of diabetes mellitus].
Pusztai P; Prechl J; Somogyi A; Szaleczky E; Fehér J
Orv Hetil; 1996 Aug; 137(34):1865-9. PubMed ID: 8927340
[TBL] [Abstract][Full Text] [Related]
4. Resistance of cats to the diabetogenic effect of alloxan.
Hatchell DL; Reiser HJ; Bresnahan JF; Whitworth UG
Lab Anim Sci; 1986 Feb; 36(1):37-40. PubMed ID: 3959532
[TBL] [Abstract][Full Text] [Related]
5. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
Liu Z; Li J; Zeng Z; Liu M; Wang M
Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
[TBL] [Abstract][Full Text] [Related]
6. Suprarenal intraarterial infusion of alloxan and streptozotocin during balloon occlusion of the juxtarenal abdominal aorta: a simple technique for inducing diabetes mellitus in canines with reduced mortality.
Salis AI; Peterson RG; Stecker MS; Patel NH; Willis LR; Galley P; Eclavea AC; Dreesen RG
Acad Radiol; 2001 Jun; 8(6):473-7. PubMed ID: 11394539
[TBL] [Abstract][Full Text] [Related]
7. Induction of type-1 diabetes mellitus in laboratory rats by use of alloxan: route of administration, pitfalls, and insulin treatment.
Federiuk IF; Casey HM; Quinn MJ; Wood MD; Ward WK
Comp Med; 2004 Jun; 54(3):252-7. PubMed ID: 15253270
[TBL] [Abstract][Full Text] [Related]
8. Impact of maternal diabetes mellitus on the thermoregulation of the offspring.
Guimarães AF; Martins CM; Luz J
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):549-54. PubMed ID: 17177136
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.
Bae SK; Kim JY; Yang SH; Kim JW; Kim T; Lee MG
Life Sci; 2006 Apr; 78(20):2287-94. PubMed ID: 16288785
[TBL] [Abstract][Full Text] [Related]
10. L-Arginine ameliorates oxidative stress in alloxan-induced experimental diabetes mellitus.
El-Missiry MA; Othman AI; Amer MA
J Appl Toxicol; 2004; 24(2):93-7. PubMed ID: 15052603
[TBL] [Abstract][Full Text] [Related]
11. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of diltiazem hydrochloride on the occurrence of alloxan- or streptozotocin-induced diabetes in rats.
Katsumata K; Katsumata K; Katsumata Y
Horm Metab Res; 1992 Nov; 24(11):508-10. PubMed ID: 1452115
[TBL] [Abstract][Full Text] [Related]
13. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
14. Variations of susceptibility to alloxan induced diabetes in the rabbit.
Zhao ZH; Watschinger B; Brown CD; Beyer MM; Friedman EA
Horm Metab Res; 1987 Nov; 19(11):534-7. PubMed ID: 3428871
[TBL] [Abstract][Full Text] [Related]
15. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan-induced diabetes mellitus.
Suresh Y; Das UN
Prostaglandins Leukot Essent Fatty Acids; 2006 Mar; 74(3):199-213. PubMed ID: 16412622
[TBL] [Abstract][Full Text] [Related]
17. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.
Amirshahrokhi K; Dehpour AR; Hadjati J; Sotoudeh M; Ghazi-Khansari M
Toxicol Appl Pharmacol; 2008 Oct; 232(1):119-24. PubMed ID: 18671992
[TBL] [Abstract][Full Text] [Related]
18. Ammonium chloride potentiation of streptozotocin-induced diabetes in juvenile pigs.
Korompai FL; Ustinova E; Taulman AC; Yuan SY
Horm Metab Res; 2000 Jul; 32(7):256-8. PubMed ID: 10965929
[TBL] [Abstract][Full Text] [Related]
19. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
[TBL] [Abstract][Full Text] [Related]
20. Effects of streptozotocin-induced diabetes in domestic pigs with focus on the amino acid metabolism.
Jensen-Waern M; Andersson M; Kruse R; Nilsson B; Larsson R; Korsgren O; Essén-Gustavsson B
Lab Anim; 2009 Jul; 43(3):249-54. PubMed ID: 19246503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
